Affiliation:
1. Russian Scientific Center of Radiology and Surgical Technologies named after academician A. M. Granov
Abstract
According to A. D. Caprin et al., [1] out of 3 630 567 patients, uterus cancer accounts for 7,1%; prostate — 6,1%; cervix — 4,9%; rectum — 4,4%; bladder — 2,99%. 30 to 50 per cent of all these patients require radiotherapy with high summary doses, palliative or symptomatic irradiation. Radiation-induced cystitis is diagnosed for in a range of 20 to 80%. Amount of publications concerning various methods of treatment of this pathology — systemic, local, using physical and different combinations — shows that there is no solid concept for prophylactics and treating of this adverse side effect of radiotherapy.
Publisher
Baltic Medical Education Center
Reference54 articles.
1. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологи- ческой помощи населению России в 2017 году. М., 2018. [Kaprin A.D., Starinsky V.V., Petrova G.V. Status of oncological assistance to the population of Russia in 2017. Moscow, 2018 (In Russ.)].
2. Siegel R.L., Miller K.D., Jemal А. Cancer Statistics, 2017 // CA Cancer J. Clin. 2017. Vol. 67 (1). Р. 7–30. DOI: 10.3322/caac.21387.
3. Бардычев М.С. Местные лучевые повреждения и их классификация // Диагностика и лечение поздних лучевых повреждений. Обнинск, 1988. С. 3–11. [Bardychev M.S. Local radiation damage and their classification. Diagnosis and treatment of late radiation damage. Obninsk, 1988. Р. 3–11 (In Russ.)].
4. Dawson L.A., Sharpe M.B. Image-guided radiotherapy: rationale, benefits, and limitations // Lancet. 2006. Vol. 17. P. 848–859.
5. Kole T.P., Tong M., Wu B. et al. Late urinary toxicitymodeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer // Acta Oncologica. 2015. Р. 1–7.